Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Arjo AB ( ($SE:ARJO.B) ) has shared an announcement.
Arjo has announced the release date for its 2025 Q3 interim report, which will be issued on October 22, followed by a conference call hosted by interim President and CEO Niclas Sjöswärd and CFO Christofer Carlsson. This announcement is significant for stakeholders, including fund managers, analysts, and media, as it provides an opportunity to engage with the company’s leadership and gain insights into Arjo’s financial performance and strategic direction.
The most recent analyst rating on ($SE:ARJO.B) stock is a Hold with a SEK35.00 price target. To see the full list of analyst forecasts on Arjo AB stock, see the SE:ARJO.B Stock Forecast page.
More about Arjo AB
Arjo is a company focused on empowering movement within healthcare environments, offering products and solutions that promote safe and dignified patient experiences. Their offerings include patient handling, medical beds, personal hygiene, disinfection, diagnostics, and prevention of pressure injuries and venous thromboembolism. With over 7,000 employees worldwide and more than 65 years of experience, Arjo is dedicated to improving outcomes for individuals with mobility challenges.
YTD Price Performance: -7.03%
Average Trading Volume: 448,951
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK8.91B
See more data about ARJO.B stock on TipRanks’ Stock Analysis page.